| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-11 | NCT07758491 A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma | Phase 1/2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06177041 | M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN)… | Locally Advanced Unresectable or Metastatic Gastric Cancer | Recruiting |
| NCT07383922 | A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive… | Pancreatic Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07623707 | A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic… | Solid Tumor | Not Yet Recruiting |
| NCT07704866 | A Phase I/II Study of FG-M108 Plus FG-B901 in Advanced CLDN18.2-Positive Solid Tumors | Claudin 18.2 | Not Yet Recruiting |
| NCT07758491 | A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma | PTCL | Not Yet Recruiting |